Clinical Trial Update: Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing apixaban to warfarin for managing postoperative atrial fibrillation after coronary artery bypass grafting; completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Grafting
• Deep Venous Thrombosis
• Postoperative Atrial Fibrillation
• Stroke
• Systemic Embolism

Drugs mentioned

• Apixaban (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Sanford Health | Conditions: Coronary Artery Bypass Grafting, Postoperative Atrial Fibrilation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-01-22